Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Oncologists who Treat Multiple Myeloma (US)

Articles with lock require a subscription to GLG News | Request a free trial
August 3, 2007
I've used it and it works, but...
Analysis of: Revimmune for Autoimmune Disease | www.pipelinereview.com
Author: GLG Expert Contributor
I participated in a number of the trials described in the article.  High dose cyclophosphamide certainally works well in a number of autoimmune diseases, but it is unclear how the use of this old drug will be protected by the company, who actually is going to be willing to administer the treatment...
July 16, 2007
Is the market alone responsible for Bexxar and Zevalin being underused?
Analysis of: Market Forces Cited in Lymphoma Drugs’ Disuse | www.nytimes.com
Author: GLG Expert Contributor
The recent article suggests that Bexxar and Zevalin are extremely effective drugs with few side effects that are infrequently prescribed because of reimbursement forces in community oncology practices.  As an academic oncologist specializing in lymphoma, I agree that these drugs are underutilized...

Page : 11 to 2 of 2

More GLG News in
Healthcare

Most Popular:
Source Article | Expert Analyses
 

GLG News: What Experts Think Is Important





Analytics


Generated at 2008-12-05T01:45:24.617